Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 1438686, 9 pages
http://dx.doi.org/10.1155/2016/1438686
Review Article

MicroRNA-Regulated Proinflammatory Cytokines in Sarcopenia

Hubei Key Laboratory of Exercise Training and Monitoring, Hubei Provincial Collaborative Innovation Center for Exercise and Health Promotion, College of Health Science, Wuhan Sports University, Wuhan 430079, China

Received 16 March 2016; Accepted 18 May 2016

Academic Editor: Mingui Fu

Copyright © 2016 Jingjing Fan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Morley, S. D. Anker, and S. von Haehling, “Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014,” Journal of Cachexia, Sarcopenia and Muscle, vol. 5, no. 4, pp. 253–259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Fan, X. Kou, S. Jia, X. Yang, Y. Yang, and N. Chen, “Autophagy as a potential target for sarcopenia,” Journal of Cellular Physiology, vol. 231, no. 7, pp. 1450–1459, 2016. View at Publisher · View at Google Scholar
  3. S. C. Kandarian and R. W. Jackman, “Intracellular signaling during skeletal muscle atrophy,” Muscle and Nerve, vol. 33, no. 2, pp. 155–165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. White, A. L. Confides, S. Moore-Reed, J. M. Hoch, and E. E. Dupont-Versteegden, “Regrowth after skeletal muscle atrophy is impaired in aged rats, despite similar responses in signaling pathways,” Experimental Gerontology, vol. 64, pp. 17–32, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Kaasik, M. Umnova, A. Pehme et al., “Ageing and dexamethasone associated sarcopenia: peculiarities of regeneration,” Journal of Steroid Biochemistry and Molecular Biology, vol. 105, no. 1–5, pp. 85–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Howard, L. Ferrucci, K. Sun et al., “Oxidative protein damage is associated with poor grip strength among older women living in the community,” Journal of Applied Physiology, vol. 103, no. 1, pp. 17–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Miller, “The aging immune system: primer and prospectus,” Science, vol. 273, no. 5271, pp. 70–74, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. E. K. Merritt, M. J. Stec, A. Thalacker-Mercer et al., “Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans,” Journal of Applied Physiology, vol. 115, no. 6, pp. 937–948, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. S. W. Lee, T.-W. Auyeung, T. Kwok, E. M. C. Lau, P.-C. Leung, and J. Woo, “Associated factors and health impact of sarcopenia in older Chinese men and women: a cross-sectional study,” Gerontology, vol. 53, no. 6, pp. 404–410, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Cai, J. D. Frantz, N. E. Tawa Jr. et al., “IKKβ/NF-κB activation causes severe muscle wasting in mice,” Cell, vol. 119, no. 2, pp. 285–298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Adler, S. Sinha, T. L. A. Kawahara, J. Y. Zhang, E. Segal, and H. Y. Chang, “Motif module map reveals enforcement of aging by continual NF-κB activity,” Genes & Development, vol. 21, no. 24, pp. 3244–3257, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. L. Budui, A. P. Rossi, and M. Zamboni, “The pathogenetic bases of sarcopenia,” Clinical Cases in Mineral and Bone Metabolism, vol. 12, no. 1, pp. 22–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Batsis, T. A. Mackenzie, J. D. Jones, F. Lopez-Jimenez, and S. J. Bartels, “Sarcopenia, sarcopenic obesity and inflammation: results from the 1999–2004 National Health and Nutrition Examination Survey,” Clinical Nutrition, 2016. View at Publisher · View at Google Scholar
  14. T. N. Kim and K. M. Choi, “The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease,” Journal of Cellular Biochemistry, vol. 116, no. 7, pp. 1171–1178, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. C. M. Phillips and I. J. Perry, “Does inflammation determine metabolic health status in obese and nonobese adults?” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 10, pp. E1610–E1619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. R. Green, L. Galluzzi, and G. Kroemer, “Mitochondria and the autophagy-inflammation-cell death axis in organismal aging,” Science, vol. 333, no. 6046, pp. 1109–1112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Ko, P. Abadir, R. Marx et al., “Impaired mitochondrial degradation by autophagy in the skeletal muscle of the aged female interleukin 10 null mouse,” Experimental Gerontology, vol. 73, pp. 23–27, 2016. View at Publisher · View at Google Scholar
  18. C. Correia-Melo, F. D. Marques, R. Anderson et al., “Mitochondria are required for pro-ageing features of the senescent phenotype,” The EMBO Journal, vol. 35, no. 7, pp. 724–742, 2016. View at Publisher · View at Google Scholar
  19. O. Kepp, L. Galluzzi, and G. Kroemer, “Mitochondrial control of the NLRP3 inflammasome,” Nature Immunology, vol. 12, no. 3, pp. 199–200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Shimada, T. R. Crother, J. Karlin et al., “Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis,” Immunity, vol. 36, no. 3, pp. 401–414, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Li and J. F. Engelhardt, “Interleukin-1β induction of NFκB is partially regulated by H2O2-mediated activation of NFκB-inducing kinase,” The Journal of Biological Chemistry, vol. 281, no. 3, pp. 1495–1505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Fan, Q. Li, Y. Zhang et al., “IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation,” The Journal of Clinical Investigation, vol. 113, no. 5, pp. 746–755, 2004. View at Publisher · View at Google Scholar
  23. S. Sriram, S. Subramanian, D. Sathiakumar et al., “Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB,” Aging Cell, vol. 10, no. 6, pp. 931–948, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. G. Rhoads, S. C. Kandarian, F. Pacelli, G. B. Doglietto, and M. Bossola, “Expression of NF-κB and IκB proteins in skeletal muscle of gastric cancer patients,” European Journal of Cancer, vol. 46, no. 1, pp. 191–197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. P. White, M. J. Puppa, S. Gao, S. Sato, S. L. Welle, and J. A. Carson, “Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK,” American Journal of Physiology—Endocrinology and Metabolism, vol. 304, no. 10, pp. E1042–E1052, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. K. L. McIntire, Y. Chen, S. Sood, and R. Rabkin, “Acute uremia suppresses leucine-induced signal transduction in skeletal muscle,” Kidney International, vol. 85, no. 2, pp. 374–382, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. W. A. He, E. Berardi, V. M. Cardillo et al., “NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia,” The Journal of Clinical Investigation, vol. 123, no. 11, pp. 4821–4835, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Wang, G. Yang, X. Liang, M. Zhu, and M. Du, “Grape seed extract prevents skeletal muscle wasting in interleukin 10 knockout mice,” BMC Complementary and Alternative Medicine, vol. 14, article 162, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Peake, P. Della Gatta, K. Suzuki, and D. C. Nieman, “Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects,” Exercise Immunology Review, vol. 21, pp. 8–25, 2015. View at Google Scholar · View at Scopus
  30. M. Podbregar, M. Lainscak, O. Prelovsek, and T. Mars, “Cytokine response of cultured skeletal muscle cells stimulated with proinflammatory factors depends on differentiation stage,” The Scientific World Journal, vol. 2013, Article ID 617170, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Molanouri Shamsi, Z. H. Hassan, R. Gharakhanlou et al., “Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training,” Endocrine, vol. 46, no. 1, pp. 60–69, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Visser, M. Pahor, D. R. Taaffe et al., “Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: the Health ABC Study,” Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, vol. 57, no. 5, pp. M326–M332, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Giuliani, P. Sansoni, G. Girasole et al., “Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes,” Experimental Gerontology, vol. 36, no. 3, pp. 547–557, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. O. P. Kristiansen and T. Mandrup-Poulsen, “Interleukin-6 and diabetes: the good, the bad, or the indifferent?” Diabetes, vol. 54, supplement 2, pp. S114–S124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Kamimura, K. Ishihara, and T. Hirano, “IL-6 signal transduction and its physiological roles: the signal orchestration model,” Reviews of Physiology, Biochemistry and Pharmacology, vol. 149, pp. 1–38, 2003. View at Google Scholar · View at Scopus
  36. W. B. Ershler and E. T. Keller, “Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty,” Annual Review of Medicine, vol. 51, pp. 245–270, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. S. K. Watkins, Z. Zhu, E. Riboldi et al., “FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer,” The Journal of Clinical Investigation, vol. 121, no. 4, pp. 1361–1372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. T. Tierney, T. Aydogdu, D. Sala et al., “STAT3 signaling controls satellite cell expansion and skeletal muscle repair,” Nature Medicine, vol. 20, no. 10, pp. 1182–1186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. C. J. Green, K. Macrae, S. Fogarty, D. G. Hardie, K. Sakamoto, and H. S. Hundal, “Counter-modulation of fatty acid-induced pro-inflammatory nuclear factor κB signalling in rat skeletal muscle cells by AMP-activated protein kinase,” Biochemical Journal, vol. 435, no. 2, pp. 463–474, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Zhang, V. Rajan, E. Lin et al., “Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease,” The FASEB Journal, vol. 25, no. 5, pp. 1653–1663, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. A. L. Carey, G. R. Steinberg, S. L. Macaulay et al., “Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase,” Diabetes, vol. 55, no. 10, pp. 2688–2697, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. C. R. Bruce and D. J. Dyck, “Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-α,” American Journal of Physiology—Endocrinology and Metabolism, vol. 287, no. 4, pp. E616–E621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Franckhauser, I. Elias, V. Rotter Sopasakis et al., “Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice,” Diabetologia, vol. 51, no. 7, pp. 1306–1316, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Haddad, F. Zaldivar, D. M. Cooper, and G. R. Adams, “IL-6-induced skeletal muscle atrophy,” Journal of Applied Physiology, vol. 98, no. 3, pp. 911–917, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg, and M. Visser, “Inflammatory markers and loss of muscle mass (sarcopenia) and strength,” The American Journal of Medicine, vol. 119, no. 6, pp. 526.e9–526.e17, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. C.-W. Yang, C.-I. Li, T.-C. Li et al., “Association of sarcopenic obesity with higher serum high-sensitivity c-reactive protein levels in Chinese older males—a community-based study (Taichung Community Health Study-Elderly, TCHS-E),” PLoS ONE, vol. 10, no. 7, article e0132908, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Girven, H. F. Dugdale, D. J. Owens, D. C. Hughes, C. E. Stewart, and A. P. Sharples, “L-glutamine improves skeletal muscle cell differentiation and prevents myotube atrophy after cytokine (TNF-α) stress via reduced p38 MAPK signal transduction,” Journal of Cellular Physiology, 2016. View at Publisher · View at Google Scholar
  48. J. S. Otis, S. Niccoli, N. Hawdon et al., “Pro-inflammatory mediation of myoblast proliferation,” PLoS ONE, vol. 9, no. 3, Article ID e92363, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Ciciliot and S. Schiaffino, “Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications,” Current Pharmaceutical Design, vol. 16, no. 8, pp. 906–914, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Luo, D. D. Hershko, B. W. Robb, C. J. Wray, and P.-O. Hasselgren, “IL-1β stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-κB,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 284, no. 5, pp. R1249–R1254, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. D.-T. Wang, Y. Yin, Y.-J. Yang et al., “Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes,” International Immunopharmacology, vol. 19, no. 2, pp. 206–213, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg et al., “Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength,” Journals of Gerontology—Series A Biological Sciences and Medical Sciences, vol. 64, no. 11, pp. 1183–1189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. J. S. Greiwe, C. Bo, D. C. Rubin, K. E. Yarasheski, and C. F. Semenkovich, “Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail elderly humans,” The FASEB Journal, vol. 15, no. 2, pp. 475–482, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Mangner, A. Linke, A. Oberbach et al., “Exercise training prevents TNF-α induced loss of force in the diaphragm of mice,” PLoS ONE, vol. 8, no. 1, Article ID e52274, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. Q. Zhao, S. T. Yang, J. J. Wang et al., “TNF alpha inhibits myogenic differentiation of C2C12 cells through NF-κB activation and impairment of IGF-1 signaling pathway,” Biochemical and Biophysical Research Communications, vol. 458, no. 4, pp. 790–795, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Coletti, V. Moresi, S. Adamo, M. Molinaro, and D. Sassoon, “Tumor necrosis factor-α gene transfer induces cachexia and inhibits muscle regeneration,” Genesis, vol. 43, no. 3, pp. 120–128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. R. A. Frost and C. H. Lang, “Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass,” Journal of Applied Physiology, vol. 103, no. 1, pp. 378–387, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. C. H. Lang, R. A. Frost, and T. C. Vary, “Regulation of muscle protein synthesis during sepsis and inflammation,” American Journal of Physiology—Endocrinology and Metabolism, vol. 293, no. 2, pp. E453–E459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. L. Di Renzo, F. Sarlo, L. Petramala et al., “Association between -308 G/A TNF- α polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndrome,” Disease Markers, vol. 35, no. 6, pp. 615–623, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Pijet, M. Pijet, A. Litwiniuk, M. Gajewska, B. Pająk, and A. Orzechowski, “TNF-α and IFN-s-dependent muscle decay is linked to NF-κB- and STAT-1α-stimulated Atrogin1 and MuRF1 genes in C2C12 myotubes,” Mediators of Inflammation, vol. 2013, Article ID 171437, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. L. S. Quinn, B. G. Anderson, L. Strait-Bodey, A. M. Stroud, and J. M. Argués, “Oversecretion of interleukin-15 from skeletal muscle reduces adiposity,” American Journal of Physiology—Endocrinology and Metabolism, vol. 296, no. 1, pp. E191–E202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Boström, J. Wu, M. P. Jedrychowski et al., “A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis,” Nature, vol. 481, no. 7382, pp. 463–468, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. M. M. Seldin and G. W. Wong, “Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines,” Adipocyte, vol. 1, no. 4, pp. 200–202, 2014. View at Publisher · View at Google Scholar
  64. A. Steensberg, C. P. Fischer, C. Keller, K. Møller, and B. K. Pedersen, “IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans,” American Journal of Physiology—Endocrinology and Metabolism, vol. 285, no. 2, pp. E433–E437, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. M. J. Drummond, K. L. Timmerman, M. M. Markofski et al., “Short-term bed rest increases TLR4 and IL-6 expression in skeletal muscle of older adults,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 305, no. 3, pp. R216–R223, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. P. S. Eisele, R. Furrer, M. Beer, and C. Handschin, “The PGC-1 coactivators promote an anti-inflammatory environment in skeletal muscle in vivo,” Biochemical and Biophysical Research Communications, vol. 464, no. 3, pp. 692–697, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Sczelecki, A. Besse-Patin, A. Abboud et al., “Loss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation,” American Journal of Physiology—Endocrinology and Metabolism, vol. 306, no. 2, pp. E157–E167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. P. S. Eisele, S. Salatino, J. Sobek, M. O. Hottiger, and C. Handschin, “The peroxisome proliferator-activated receptor γ coactivator 1α/β (PGC-1) coactivators repress the transcriptional activity of NF-κB in skeletal muscle cells,” Journal of Biological Chemistry, vol. 288, no. 4, pp. 2246–2260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Wenz, S. G. Rossi, R. L. Rotundo, B. M. Spiegelman, and C. T. Moraes, “Increased muscle PGC-1α expression protects from sarcopenia and metabolic disease during aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 48, pp. 20405–20410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. N. Bushati and S. M. Cohen, “MicroRNA functions,” Annual Review of Cell and Developmental Biology, vol. 23, pp. 175–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Zacharewicz, S. Lamon, and A. P. Russell, “MicroRNAs in skeletal muscle and their regulation with exercise, ageing, and disease,” Frontiers in Physiology, vol. 4, article 266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Guo, N. T. Ingolia, J. S. Weissman, and D. P. Bartel, “Mammalian microRNAs predominantly act to decrease target mRNA levels,” Nature, vol. 466, no. 7308, pp. 835–840, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Han, Y. Lee, K.-H. Yeom et al., “Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex,” Cell, vol. 125, no. 5, pp. 887–901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. K. W. Diebel, D. J. Claypool, and L. F. van Dyk, “A conserved RNA polymerase III promoter required for gammaherpesvirus TMER transcription and microRNA processing,” Gene, vol. 544, no. 1, pp. 8–18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Winter, S. Jung, S. Keller, R. I. Gregory, and S. Diederichs, “Many roads to maturity: MicroRNA biogenesis pathways and their regulation,” Nature Cell Biology, vol. 11, no. 3, pp. 228–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. Cui, T. Huang, and X. Zhang, “RNA editing of microRNA prevents RNA-induced silencing complex recognition of target mRNA,” Open Biology, vol. 5, no. 12, Article ID 150126, 2015. View at Publisher · View at Google Scholar
  77. P. Brodersen and O. Voinnet, “Revisiting the principles of microRNA target recognition and mode of action,” Nature Reviews Molecular Cell Biology, vol. 10, no. 2, pp. 141–148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. Z. Hu and A. E. Bruno, “The influence of 3′UTRs on MicroRNA function inferred from human SNP data,” Comparative and Functional Genomics, vol. 2011, Article ID 910769, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Kim, B. Kim, and V. N. Kim, “Re-evaluation of the roles of DROSHA, Exportin 5, and DICER in microRNA biogenesis,” Proceedings of the National Academy of Sciences, vol. 113, no. 13, pp. E1881–E1889, 2016. View at Publisher · View at Google Scholar
  80. J. Brennecke, A. Stark, R. B. Russell, and S. M. Cohen, “Principles of microRNA-target recognition,” PLoS Biology, vol. 3, no. 3, article e85, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Quattrocelli and M. Sampaolesi, “The mesmiRizing complexity of microRNAs for striated muscle tissue engineering,” Advanced Drug Delivery Reviews, vol. 88, pp. 37–52, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. D. Baltimore, M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov, “MicroRNAs: new regulators of immune cell development and function,” Nature Immunology, vol. 9, no. 8, pp. 839–845, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. E. van Rooij, N. Liu, and E. N. Olson, “MicroRNAs flex their muscles,” Trends in Genetics, vol. 24, no. 4, pp. 159–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. E. M. Small, J. R. O'Rourke, V. Moresi et al., “Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 9, pp. 4218–4223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. T. E. Callis, Z. Deng, J.-F. Chen, and D.-Z. Wang, “Muscling through the microRNA world,” Experimental Biology and Medicine, vol. 233, no. 2, pp. 131–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. E. van Rooij, D. Quiat, B. A. Johnson et al., “A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance,” Developmental Cell, vol. 17, no. 5, pp. 662–673, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. J.-F. Chen, T. E. Callis, and D.-Z. Wang, “microRNAs and muscle disorders,” Journal of Cell Science, vol. 122, no. 1, pp. 13–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Nakasa, M. Ishikawa, M. Shi, H. Shibuya, N. Adachi, and M. Ochi, “Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model,” Journal of Cellular and Molecular Medicine, vol. 14, no. 10, pp. 2495–2505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. M. J. Drummond, J. J. McCarthy, C. S. Fry, K. A. Esser, and B. B. Rasmussen, “Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids,” American Journal of Physiology—Endocrinology and Metabolism, vol. 295, no. 6, pp. E1333–E1340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Contreras and D. S. Rao, “MicroRNAs in inflammation and immune responses,” Leukemia, vol. 26, no. 3, pp. 404–413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. B. Schroen and S. Heymans, “Small but smartmicroRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing,” Cardiovascular Research, vol. 93, no. 4, pp. 605–613, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. E. M. Mercken, E. Majounie, J. Ding et al., “Age-associated miRNA alterations in skeletal muscle from rhesus monkeys reversed by caloric restriction,” Aging, vol. 5, no. 9, pp. 692–703, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. Q.-J. Li, J. Chau, P. J. R. Ebert et al., “miR-181a is an intrinsic modulator of T cell sensitivity and selection,” Cell, vol. 129, no. 1, pp. 147–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Soriano-Arroquia, L. House, L. Tregilgas, E. Canty-Laird, and K. Goljanek-Whysall, “The functional consequences of age-related changes in microRNA expression in skeletal muscle,” Biogerontology, 2016. View at Publisher · View at Google Scholar
  95. W. Xie, Z. Li, M. Li, N. Xu, and Y. Zhang, “miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo,” Biochemical and Biophysical Research Communications, vol. 430, no. 2, pp. 647–652, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. R. W. Georgantas, K. Streicher, S. A. Greenberg et al., “Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies,” Arthritis and Rheumatology, vol. 66, no. 4, pp. 1022–1033, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. R. S. Yadava, E. P. Foff, Q. Yu et al., “TWEAK/Fn14, a pathway and novel therapeutic target in myotonic dystrophy,” Human Molecular Genetics, vol. 24, no. 7, pp. 2035–2048, 2015. View at Publisher · View at Google Scholar · View at Scopus
  98. S. K. Panguluri, S. Bhatnagar, A. Kumar et al., “Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice,” PLoS ONE, vol. 5, no. 1, Article ID e8760, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Roush and F. J. Slack, “The let-7 family of microRNAs,” Trends in Cell Biology, vol. 18, no. 10, pp. 505–516, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. M. J. Drummond, J. J. McCarthy, M. Sinha et al., “Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis,” Physiological Genomics, vol. 43, no. 10, pp. 595–603, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. L. Q. Jiang, N. Franck, B. Egan et al., “Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7,” American Journal of Physiology—Endocrinology and Metabolism, vol. 305, no. 11, pp. E1359–E1366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. J. H. Yu, L. Long, Z. X. Luo, L. M. Li, and J. R. You, “Anti-inflammatory role of microRNA let-7c in LPS treated alveolar macrophages by targeting STAT3,” Asian Pacific Journal of Tropical Medicine, vol. 9, no. 1, pp. 72–75, 2016. View at Publisher · View at Google Scholar
  103. M. Jiang, Y. Xiang, D. Wang et al., “Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages,” Aging Cell, vol. 11, no. 1, pp. 29–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. F. Olivieri, M. R. Rippo, F. Prattichizzo et al., “Toll like receptor signaling in ‘inflammaging’: microRNA as new players,” Immunity and Ageing, vol. 10, no. 1, article 111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. L. N. Schulte, A. J. Westermann, and J. Vogel, “Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing,” Nucleic Acids Research, vol. 41, no. 1, pp. 542–553, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. I. Eisenberg, A. Eran, I. Nishino et al., “Distinctive patterns of microRNA expression in primary muscular disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17016–17021, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. H. Y. Seok, M. Tatsuguchi, T. E. Callis, A. He, W. T. Pu, and D.-Z. Wang, “miR-155 inhibits expression of the MEF2A protein to repress skeletal muscle differentiation,” The Journal of Biological Chemistry, vol. 286, no. 41, pp. 35339–35346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. K. D. Taganov, M. P. Boldin, K.-J. Chang, and D. Baltimore, “NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12481–12486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. E. Tili, J.-J. Michaille, A. Cimino et al., “Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF- α stimulation and their possible roles in regulating the response to endotoxin shock,” Journal of Immunology, vol. 179, no. 8, pp. 5082–5089, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. A. P. Russell, S. Wada, L. Vergani et al., “Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis,” Neurobiology of Disease, vol. 49, no. 1, pp. 107–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  111. W. Aoi, Y. Naito, K. Mizushima et al., “The microRNA miR-696 regulates PGC-1α in mouse skeletal muscle in response to physical activity,” American Journal of Physiology—Endocrinology and Metabolism, vol. 298, no. 4, pp. E799–E806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. G. L. Jensen, “Inflammation: roles in aging and sarcopenia,” Journal of Parenteral and Enteral Nutrition, vol. 32, no. 6, pp. 656–659, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. A. M. Villani, M. Crotty, I. D. Cameron et al., “Appendicular skeletal muscle in hospitalised hip-fracture patients: development and cross-validation of anthropometric prediction equations against dual-energy X-ray absorptiometry,” Age and Ageing, vol. 43, no. 6, pp. 857–862, 2014. View at Publisher · View at Google Scholar · View at Scopus